Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Shaanxi Meibang Pharmaceutical Group Co., Ltd. (605033.SS)

16.97
+0.55
+(3.35%)
At close: 3:00:04 PM GMT+8
Loading Chart for 605033.SS
  • Previous Close 16.42
  • Open 16.70
  • Bid 16.97 x --
  • Ask 16.98 x --
  • Day's Range 16.48 - 16.98
  • 52 Week Range 9.73 - 32.86
  • Volume 3,207,788
  • Avg. Volume 5,601,243
  • Market Cap (intraday) 2.294B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 106.06
  • EPS (TTM) 0.16
  • Earnings Date --
  • Forward Dividend & Yield 0.20 (1.19%)
  • Ex-Dividend Date Dec 19, 2024
  • 1y Target Est --

Shaanxi Meibang Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pesticide preparations. Its products include insecticides, fungicides, herbicides, plant growth regulators, fertilizers, and microbial fertilizers. The company is also engaged in the sales of agricultural machinery, fertilizers, and agricultural and sideline products, as well as offers technical consulting services. The company was founded in 1998 and is headquartered in Xi'an, China.

www.meibang.cn

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 605033.SS

View More

Performance Overview: 605033.SS

Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

605033.SS
41.06%
SSE Composite Index (000001.SS)
1.06%

1-Year Return

605033.SS
12.46%
SSE Composite Index (000001.SS)
5.58%

3-Year Return

605033.SS
17.54%
SSE Composite Index (000001.SS)
10.48%

5-Year Return

605033.SS
11.42%
SSE Composite Index (000001.SS)
15.22%

Compare To: 605033.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 605033.SS

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    2.22B

  • Enterprise Value

    1.80B

  • Trailing P/E

    102.62

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.60

  • Price/Book (mrq)

    1.92

  • Enterprise Value/Revenue

    2.08

  • Enterprise Value/EBITDA

    75.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.59%

  • Return on Assets (ttm)

    0.65%

  • Return on Equity (ttm)

    1.93%

  • Revenue (ttm)

    862.85M

  • Net Income Avi to Common (ttm)

    22.37M

  • Diluted EPS (ttm)

    0.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    494.5M

  • Total Debt/Equity (mrq)

    6.24%

  • Levered Free Cash Flow (ttm)

    140.28M

Research Analysis: 605033.SS

View More

Company Insights: 605033.SS

Research Reports: 605033.SS

View More

People Also Watch